Baby Aspirin Reduces Cancer Risk |
A new analysis combining the results from eight long-term studies of the effects of low-dose aspirin now finds a significant reduction in deaths from a variety of cancers, most notably those of the digestive tract, but also cancer of the brain, lungs, prostate and pancreas.
Overall,taking low-dose aspirin for five years or more appeared to reduce the overall death rate from cancer by more than 20 percent.
You can read a summary of these findings on Suite101.
And, if you're interested, you can read the original paper in The Lancet.
Robert Adler
No comments:
Post a Comment